Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F3J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,531
Award facts
- Contract value 100% obligated
- $13,530.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Cosentyx (secukinumab) 300mg dose at a contract ceiling value of $13,530.52. This firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will be executed at the vendor's headquarters in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat various inflammatory conditions, supporting the Department of Defense's medical supply chain requirements for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999,999,999 IDC with DLA Troop Support Medical (contract SPE2DX) extending through December 2026, which serves as the parent contract vehicle for this delivery order. The company's federal contract portfolio demonstrates extensive experience supplying brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the Defense Health Agency's pharmaceutical supply network, enabling efficient procurement of specialized medications needed for military medical operations.
Quick answers
Who was awarded contract SPE2DR26F5F3J?
SPE2DR26F5F3J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F5F3J worth?
The government has obligated $13,531 on SPE2DR26F5F3J.
Is contract SPE2DR26F5F3J an order under another contract?
Yes. SPE2DR26F5F3J is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F3J competed?
The extent of competition for SPE2DR26F5F3J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award